Literature DB >> 27894718

Chlamydia suis and Chlamydia trachomatis induce multifunctional CD4 T cells in pigs.

T Käser1, J A Pasternak2, M Delgado-Ortega2, G Hamonic2, K Lai2, J Erickson2, S Walker2, J R Dillon2, V Gerdts2, F Meurens3.   

Abstract

Chlamydia trachomatis infections are the most prominent bacterial sexually-transmitted disease world-wide and a lot of effort is put into the development of an effective vaccine. Pigs have been shown to be a valuable animal model for C. trachomatis vaccine development. The aim of this study was to decipher the T-cell-mediated immune response to chlamydial infections including C. trachomatis and C. suis, the chlamydia species naturally infecting pigs with a demonstrated zoonotic potential. Vaginal infection of pigs with C. suis and C. trachomatis lasted from 3 to 21days and intra-uterine infection was still present after 21days in 3 out of 5 C. suis- and 4 out of 5 C. trachomatis-inoculated animals and caused severe pathological changes. Humoral immune responses including neutralizing antibodies were found predominantly in response to C. suis starting at 14days post inoculation. The T-cell-mediated immune responses to C. trachomatis and C. suis-infections started at 7days post inoculation and consisted mainly of CD4+ T cells which were either IFN-γ single cytokine-producing or IFN-γ/TNF-α double cytokine-producing T-helper 1 cells. IL-17-producing CD4+ T cells were rare or completely absent. The T-cell-mediated immune responses were triggered by both homologous or heterologous re-stimulation indicating that cross-protection between the two chlamydia species is possible. Thus, having access to a working genital C. suis and C. trachomatis infection model, efficient monitoring of the host-pathogen interactions, and being able to accurately assess the responses to infection makes the pig an excellent animal model for vaccine development which also could bridge the gap to the clinical phase for C. trachomatis vaccine research. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animal model; Chlamydia suis; Chlamydia trachomatis; One Health; Swine; Vaccine development

Mesh:

Substances:

Year:  2016        PMID: 27894718     DOI: 10.1016/j.vaccine.2016.11.050

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Towards a deeper understanding of the vaginal microbiota.

Authors:  Michael France; Madeline Alizadeh; Sarah Brown; Bing Ma; Jacques Ravel
Journal:  Nat Microbiol       Date:  2022-03-04       Impact factor: 30.964

2.  Comparison of Lethal and Nonlethal Mouse Models of Orientia tsutsugamushi Infection Reveals T-Cell Population-Associated Cytokine Signatures Correlated with Lethality and Protection.

Authors:  Alison Luce-Fedrow; Suchismita Chattopadhyay; Teik-Chye Chan; Gregory Pearson; John B Patton; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2021-07-02

3.  Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs.

Authors:  Shradha Wali; Rishein Gupta; Jieh-Juen Yu; Gopala Krishna Koundinya Lanka; James P Chambers; M Neal Guentzel; Guangming Zhong; Ashlesh K Murthy; Bernard P Arulanandam
Journal:  Immunol Cell Biol       Date:  2016-12-19       Impact factor: 5.126

Review 4.  The pig as a model for immunology research.

Authors:  Reinhard Pabst
Journal:  Cell Tissue Res       Date:  2020-04-30       Impact factor: 5.249

5.  The T-Cell Response to Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).

Authors:  Andrew R Kick; Amanda F Amaral; Lizette M Cortes; Jonathan E Fogle; Elisa Crisci; Glen W Almond; Tobias Käser
Journal:  Viruses       Date:  2019-08-29       Impact factor: 5.048

6.  Mucosal Vaccination with UV-Inactivated Chlamydia suis in Pre-Exposed Outbred Pigs Decreases Pathogen Load and Induces CD4 T-Cell Maturation into IFN-γ+ Effector Memory Cells.

Authors:  Amanda F Amaral; Khondaker S Rahman; Andrew R Kick; Lizette M Cortes; James Robertson; Bernhard Kaltenboeck; Volker Gerdts; Catherine M O'Connell; Taylor B Poston; Xiaojing Zheng; Chuwen Liu; Sam Y Omesi; Toni Darville; Tobias Käser
Journal:  Vaccines (Basel)       Date:  2020-07-02

7.  The Local and Systemic Humoral Immune Response Against Homologous and Heterologous Strains of the Type 2 Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Andrew R Kick; Amanda F Amaral; Alba Frias-De-Diego; Lizette M Cortes; Jonathan E Fogle; Elisa Crisci; Glen W Almond; Tobias Käser
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

8.  Vaccination and Infection of Swine With Salmonella Typhimurium Induces a Systemic and Local Multifunctional CD4+ T-Cell Response.

Authors:  Selma Schmidt; Elena L Sassu; Eleni Vatzia; Alix Pierron; Julia Lagler; Kerstin H Mair; Maria Stadler; Christian Knecht; Joachim Spergser; Marlies Dolezal; Sven Springer; Tobias Theuß; Vicky Fachinger; Andrea Ladinig; Armin Saalmüller; Wilhelm Gerner
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

9.  Prophylactic Multi-Subunit Vaccine against Chlamydia trachomatis: In Vivo Evaluation in Mice.

Authors:  Christian Lanfermann; Sebastian Wintgens; Thomas Ebensen; Martin Kohn; Robert Laudeley; Kai Schulze; Claudia Rheinheimer; Johannes H Hegemann; Carlos Alberto Guzmán; Andreas Klos
Journal:  Vaccines (Basel)       Date:  2021-06-06

10.  Assessment of Immunological Response and Impacts on Fertility Following Intrauterine Vaccination Delivered to Swine in an Artificial Insemination Dose.

Authors:  Glenn Hamonic; J Alex Pasternak; Siew Hon Ng; Kezia R Fourie; Olena M Simko; Brodie Deluco; Heather L Wilson
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.